Gene: TSC22D2
Official Full Name: TSC22 domain family member 2provided by HGNC
Gene Summary: Involved in negative regulation of cell cycle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32714 | TSC22D2 Knockout cell line (HeLa) | Human | TSC22D2 | 1:3~1:6 | Negative | Online Inquiry |
KO32715 | TSC22D2 Knockout cell line (HCT 116) | Human | TSC22D2 | 1:2~1:4 | Negative | Online Inquiry |
KO32716 | TSC22D2 Knockout cell line (HEK293) | Human | TSC22D2 | 1:3~1:6 | Negative | Online Inquiry |
TSC22D2 Gene Knockout Cell Lines are engineered cell lines that have undergone targeted gene disruption of the TSC22 domain family member 2 (TSC22D2) gene. This gene is notable for its roles in cellular regulation, apoptosis, and cancer biology. By employing advanced CRISPR/Cas9 gene-editing technology, these cell lines allow for the precise deletion of the TSC22D2 gene, enabling researchers to explore its function and contribution to various biological processes in vitro.
The key functions of TSC22D2 include modulation of stress responses and the regulation of inflammatory pathways. The knockout of this gene can induce phenotypic changes in cell proliferation, differentiation, and survival, thus providing insights into its specific roles under normal and pathological conditions. Researchers can use these knockout cell lines to elucidate the mechanisms by which TSC22D2 influences critical signaling pathways, making them invaluable tools for studying diseases such as cancer, autoimmune disorders, and metabolic syndromes.
The scientific importance of TSC22D2 Gene Knockout Cell Lines extends to both basic research and clinical implications. By understanding the functional relevance of TSC22D2 in cell biology, researchers can identify potential therapeutic targets, paving the way for novel treatment strategies and biomarker discovery. Compared to conventional methods such as RNA interference, which may not achieve complete gene knockdown, these knockout cell lines provide a more comprehensive approach to studying gene function, enabling more robust and reproducible results.
In addition to their technical advantages, TSC22D2 Gene Knockout Cell Lines are offered with extensive support, including characterization data and protocols, which enhances user experience and experimental design. For researchers and clinicians alike, the availability of these specialized cell lines represents a critical resource that drives innovative research and facilitates breakthroughs in understanding complex biological systems.
Backed by our company's commitment to excellence in biological products and extensive experience in gene editing technologies, TSC22D2 Gene Knockout Cell Lines are not just tools; they are gateways to advancing scientific discovery and improving human health.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.